A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia: is immunosuppression a risk factor for SARS-COV2 infection?
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) associated disease (COVID-19), recently reported in Wuhan, is causing an unprecedented pandemia. Patients typically present with fever, cough and dyspnea. Advanced age, cardiovascular disease (CVD), diabetes (DM) and lung disease (LD) have been related with worse clinical outcome [1].
Source: Lung Cancer - Category: Cancer & Oncology Authors: Mar ía Sereno, Gerardo Gutiérrez-Gutiérrez, Carmen Sandoval, Sandra Falagan, Ana María Jimenez-Gordo, María Merino, Ramiro López-Menchaca, Patricia Martínez Martín, Silvia Roa, Enrique Casado Tags: Correspondence Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Coronavirus | Cough | COVID-19 | Diabetes | Endocrinology | Heart | Lung Cancer | Men | Pneumonia | Respiratory Medicine | SARS